United European Gastroenterol J. 2015 Oct;3(5):443-52. doi: 10.1177/2050640614558343.
Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease.
United European gastroenterology journal
N Vakil, A Niklasson, H Denison, A Rydén
Affiliations
Affiliations
- University of Wisconsin Medical School and Public Health, Madison, USA.
- AstraZeneca R&D, Mölndal, Sweden.
PMID: 26535123
PMCID: PMC4625745 DOI: 10.1177/2050640614558343
Abstract
BACKGROUND: Gender differences may exist in the symptom experience of patients with gastro-oesophageal reflux disease (GERD) who have a partial response to proton pump inhibitors (PPIs).
OBJECTIVE: The purpose of this study was to analyse gender differences in partial responders to PPIs.
METHODS: Patients with GERD who responded partially to PPIs (n = 580; NCT00703534) completed the Reflux Symptom Questionnaire 7-day recall (RESQ-7) and the Gastrointestinal Symptom Rating Scale (GSRS). Anxiety and depression were evaluated using the Hospital Anxiety and Depression Scale.
RESULTS: Women had significantly higher RESQ-7 domain scores than men for Heartburn (frequency: 4.3 vs 3.9; intensity: 3.1 vs 2.8), Burping (frequency: 4.9 vs 4.4; intensity: 3.1 vs 2.8) and Hoarseness, cough and difficulty swallowing (frequency: 2.6 vs 2.2; intensity: 1.8 vs 1.5), and had higher GSRS domain discomfort scores than men for Abdominal pain (3.51 vs 3.23), Indigestion (3.80 vs 3.45) and Constipation (2.69 vs 2.17) (all p < 0.05). Anxiety and depression were significantly more prevalent in women than in men.
CONCLUSION: In this population of partial responders, women had more frequent/intense heartburn and extra-oesophageal symptoms and more discomfort from abdominal pain, indigestion and constipation than men. Comorbid anxiety and depression may contribute to the increased symptom burden in women.
Keywords: Abdominal pain; extra-oesophageal symptoms; gastro-oesophageal reflux disease; gender differences; heartburn
References
- Gastroenterology. 2006 Apr;130(5):1466-79 - PubMed
- Gut. 2012 Apr;61(4):501-6 - PubMed
- Aliment Pharmacol Ther. 2011 Sep;34(6):618-27 - PubMed
- Aliment Pharmacol Ther. 2003 Jun 15;17(12):1515-20 - PubMed
- Gastroenterol Hepatol. 2004 May;27(5):300-6 - PubMed
- Aliment Pharmacol Ther. 2009 Feb 15;29(4):351-8 - PubMed
- Am J Gastroenterol. 2012 Jul;107(7):991-1000 - PubMed
- Aliment Pharmacol Ther. 2012 Oct;36(7):635-43 - PubMed
- Acta Psychiatr Scand. 1983 Jun;67(6):361-70 - PubMed
- Gastroenterology. 2008 Mar;134(3):696-705 - PubMed
- Scand J Gastroenterol. 2006 Mar;41(3):288-93 - PubMed
- Arch Gen Psychiatry. 2009 Jul;66(7):785-95 - PubMed
- Gut. 2008 Oct;57(10):1354-9 - PubMed
- Aliment Pharmacol Ther. 2009 May 1;29(9):959-66 - PubMed
- Dis Esophagus. 2012 Feb;25(2):107-13 - PubMed
- Przegl Epidemiol. 2005;59(1):75-85 - PubMed
- World J Gastroenterol. 2011 Jul 21;17(27):3235-41 - PubMed
- BMC Gastroenterol. 2011 May 11;11:52 - PubMed
- Am J Gastroenterol. 2011 Aug;106(8):1419-25; quiz 1426 - PubMed
- Scand J Gastroenterol. 1995 Nov;30(11):1046-52 - PubMed
- Scand J Gastroenterol. 2005 Mar;40(3):275-85 - PubMed
- Aliment Pharmacol Ther. 2010 Sep;32(6):720-37 - PubMed
- Aliment Pharmacol Ther. 2008 Mar 15;27(6):473-82 - PubMed
- Scand J Gastroenterol. 2012 Jul;47(7):751-61 - PubMed
- Scand J Gastroenterol. 2007 Aug;42(8):951-6 - PubMed
- Clin Gastroenterol Hepatol. 2012 Jun;10(6):612-9 - PubMed
- Scand J Gastroenterol. 2013 Sep;48(9):1018-26 - PubMed
- Aliment Pharmacol Ther. 2012 May;35(9):1073-9 - PubMed
- Z Gastroenterol. 2003 Dec;41(12):1137-43 - PubMed
- Am J Gastroenterol. 2009 Aug;104(8):1992-7 - PubMed
- Clin Transl Gastroenterol. 2012 Jan 26;3:e7 - PubMed
Publication Types